Ryan M Davis

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector
    Ryan M Davis
    Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    Free Radic Biol Med 51:780-90. 2011
  2. ncbi Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape
    Ryan M Davis
    Radiation Biology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Free Radic Biol Med 50:459-68. 2011
  3. ncbi Nitroxides as cancer imaging agents
    Ryan M Davis
    Radiation Biology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Agents Med Chem 11:347-58. 2011
  4. ncbi The relationship between tissue oxygenation and redox status using magnetic resonance imaging
    Fuminori Hyodo
    Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
    Int J Oncol 41:2103-8. 2012

Collaborators

Detail Information

Publications4

  1. ncbi A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector
    Ryan M Davis
    Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    Free Radic Biol Med 51:780-90. 2011
    ..The data in this report suggest that 23c is currently the most potent known nitroxide radioprotector, and that it may also be useful as a contrast agent for functional imaging...
  2. ncbi Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape
    Ryan M Davis
    Radiation Biology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Free Radic Biol Med 50:459-68. 2011
    ..For the purpose of redox imaging, 3-CP was shown to be an optimal choice based on the achievable concentrations and bioreduction observed in vivo...
  3. ncbi Nitroxides as cancer imaging agents
    Ryan M Davis
    Radiation Biology Branch, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA
    Anticancer Agents Med Chem 11:347-58. 2011
    ..The potential therapeutic applications and bio-reduction mechanisms are discussed in the context of their relevance to oncology...
  4. ncbi The relationship between tissue oxygenation and redox status using magnetic resonance imaging
    Fuminori Hyodo
    Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
    Int J Oncol 41:2103-8. 2012
    ..The results show that rapid Tempol reduction correlates with decreased tumor oxygenation, and that the Tempol decay rate constant may be a surrogate marker for tumor hypoxia...